10 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

0.9% Sodium Chloride Injection, USP, Pre-filled COP Syringe

FDA 510(k)
FDA Class 2 ·General Hospital

Sonic

FDA UDI
Sonic Innovations, Inc.·05711583031972·ET40 B 105, 2.4G NFM DPB GR ENCHANT 40

MAMMOSITE II RADIATION THERAPY SYSTEM

FDA 510(k)
FDA Class 2 ·Radiology

FRANKENMAN SURGICAL STAPLERS

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

STARCLOSE SE VASCULAR CLOSURE SYSTEM

FDA Adverse Event
Injury ·AV-TEMECULA-CT·Product code MGB·August 4, 2011

SYNCHROMED II

FDA Adverse Event
Injury ·MDT PUERTO RICO OPERATIONS CO·Product code LKK·June 26, 2013

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·October 21, 2014

Blood Pressure Module BPM3 TM-2917B (Spare Part Numbers 191378 or 191389) with firmware version S005 installed in 2008 Series Hemodialysis Machines with Part Numbers 190573, 190713, 190766, 190858, 190895, 190908, 191124, 191126, 191128, and 191130

FDA Recall
Open, Classified ·Fresenius Medical Care Holdings, Inc.·Product code KDI·August 8, 2024

Blood Pressure Module BPM3 TM-2917B (Spare Part Numbers 191378 or 191389) with firmware version S005 installed in 2008 Series Hemodialysis Machines with Part Numbers 190573, 190713, 190766, 190858, 190895, 190908, 191124, 191126, 191128, and 191130

FDA Enforcement
Class II ·Ongoing·Fresenius Medical Care Holdings, Inc.·September 18, 2024

St. Jude Medical CONFIRM Rx Insertable Cardiac Monitor, Sterile EO, Model #: DM3500 The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 11, 2018